Overview

Pharmacokinetics and Safety Study of Apetrol ES in Healthy Male Volunteers

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
A Randomized, Open Label, Single dose, Cross-over, Phase I Trial to Investigate Safety and Pharmacokinetics of Apetrol ES and MegaceĀ® under Fed Conditions in Healthy Male Volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
LG Life Sciences
Collaborator:
Asan Medical Center
Treatments:
Megestrol Acetate